mTOR Signaling and Cancer Progression
PI3K/mTOR/AKT Signaling Pathway
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Control System Problem
Combinatorial Gene Control
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 12, 2026

A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction
Published on: August 27, 2019
Jingyue Jia1, Yakubu Princely Abudu2, Aurore Claude-Taupin1
1Autophagy Inflammation and Metabolism Center of Biomedical Research Excellence, University of New Mexico Health Sciences Center, 915 Camino de Salud, NE, Albuquerque, NM 87131, USA; Department of Molecular Genetics and Microbiology, University of New Mexico Health Sciences Center, 915 Camino de Salud, NE, Albuquerque, NM 87131, USA.
Lysosomal damage inhibits the mTOR pathway via galectin-8 (Gal8), activating autophagy and defense mechanisms. This discovery reveals a new galectin-based signaling system (GALTOR) that regulates mTOR in response to cellular injury.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: